Preclinical study shines a light on BET inhibitors' potential to prevent obesity-related cancer growth
A small molecule inhibitor of the bromodomain and extra-terminal protein family (BET) may slow down and even prevent the growth of breast and lung cancers …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
